CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L405. A total of 12 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $23,000 | -42.5% | 60,125 | 0.0% | 0.00% | – |
| Q4 2019 | $40,000 | +33.3% | 60,125 | -20.0% | 0.00% | – |
| Q3 2019 | $30,000 | -26.8% | 75,125 | 0.0% | 0.00% | – |
| Q2 2019 | $41,000 | -41.4% | 75,125 | 0.0% | 0.00% | – |
| Q1 2019 | $70,000 | +133.3% | 75,125 | +49.9% | 0.00% | – |
| Q4 2018 | $30,000 | -56.5% | 50,125 | 0.0% | 0.00% | – |
| Q3 2018 | $69,000 | +21.1% | 50,125 | +24.9% | 0.00% | – |
| Q2 2018 | $57,000 | +39.0% | 40,125 | +33.2% | 0.00% | – |
| Q1 2018 | $41,000 | -21.2% | 30,125 | 0.0% | 0.00% | – |
| Q4 2017 | $52,000 | +40.5% | 30,125 | +49.7% | 0.00% | – |
| Q3 2017 | $37,000 | -2.6% | 20,125 | +98.8% | 0.00% | – |
| Q2 2017 | $38,000 | -35.6% | 10,125 | -36.6% | 0.00% | – |
| Q1 2017 | $59,000 | +1.7% | 15,958 | +45.6% | 0.00% | – |
| Q4 2016 | $58,000 | – | 10,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 50,232 | $34,000 | 0.00% |
| Renaissance Technologies | 1,269,326 | $850,000 | 0.00% |
| VANGUARD GROUP INC | 106,172 | $71,000 | 0.00% |
| UBS Group AG | 7,627 | $5,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 9 | $0 | 0.00% |
| NORTHERN TRUST CORP | 13,399 | $9,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 162,686 | $108,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,286 | $0 | 0.00% |
| BlackRock Inc. | 796 | $1,000 | 0.00% |